At a glance
- Originator Abbott Laboratories; Fujian Institute of Medical Science; Harold C. Simmons Arthritis Research Center; National Cancer Center (Tokyo); Pharmagenesis; Stanford University; University of Texas Southwestern Medical Center
- Class Antineoplastics; Diterpenes; Epoxy compounds; Phenanthrenes
- Mechanism of Action Immunomodulators; Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Gastric cancer; Inflammation; Rheumatoid arthritis; Solid tumours; Transplant rejection